Goodwill and Other Impairments - Additional Information (Detail) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
Mar. 31, 2019 |
|
| Finite Lived Intangible Assets [Line Items] | |||
| Intangible amortization expense | $ 11 | $ 237 | |
| Impairment of goodwill and intangible assets | $ 184 | 6,449 | |
| Impairment losses, goodwill | 1,222 | ||
| Permits [Member] | |||
| Finite Lived Intangible Assets [Line Items] | |||
| Impairment losses, intangible assets | 1,700 | ||
| Tradename [Member] | |||
| Finite Lived Intangible Assets [Line Items] | |||
| Impairment losses, intangible assets | 2,000 | ||
| Customer Relationships [Member] | |||
| Finite Lived Intangible Assets [Line Items] | |||
| Intangible amortization expense | $ 0 | $ 0 | 180 |
| Impairment losses, intangible assets | 1,208 | ||
| Other Long-Lived Assets [Member] | |||
| Finite Lived Intangible Assets [Line Items] | |||
| Impairment losses, intangible assets | $ 319 | ||
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|